Catalysts for City of Hope

City of Hope — CHOP [cyclophosphamide + doxorubicin + vincristine + prednisolone] (Phase I Trial Initiation)

City of Hope — Methotrexate Teva (Phase II Trial Results)

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Role and regulation of methylarginine effector TDRD3 in T cell immunity

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — A novel pentavalent circular RNA-based EBV vaccine

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — An exosome-based liquid biopsy assay for the non-invasive early detection of ...

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — The Novel Role and Mechanism of RBM33 in Leukemogenesis

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — DYRK1A inhibitors, GLP1 Receptor Agonists and Immunomodulation for Beta Cell ...

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Molecular Mechanisms Governing Non-canonical miR-146a Biogenesis

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — The role of ALKBH5-mediated RNA demethylation in the maintenance of genomic s...

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — 2025 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — The gut-fat crosstalk in metabolic regulation

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Alpha Cell Heterogeneity: Unveiling Novel Targets for T1D therapy